arrow
T

Teruhiko Mizumoto

kumamoto university
H指数:11
被引数:717

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alvespimycin is identified as a novel therapeutic agent for diabetic kidney disease by chemical screening targeting extracellular vesicles

Alvespimycin通过靶向细胞外囊泡的化学筛选被鉴定为糖尿病肾病的新型治疗剂。

2025-04-250
OA
A serine protease inhibitor camostat mesilate prevents podocyte apoptosis and attenuates podocyte injury in metabolic syndrome model rats
2021-08-014
OAAI
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model
2016-02-0110
OAAI